CA2481394A1 - Preparation ophthalmologique en gel formant des gouttes et contenant de la diclofenamide et du timolol - Google Patents
Preparation ophthalmologique en gel formant des gouttes et contenant de la diclofenamide et du timolol Download PDFInfo
- Publication number
- CA2481394A1 CA2481394A1 CA002481394A CA2481394A CA2481394A1 CA 2481394 A1 CA2481394 A1 CA 2481394A1 CA 002481394 A CA002481394 A CA 002481394A CA 2481394 A CA2481394 A CA 2481394A CA 2481394 A1 CA2481394 A1 CA 2481394A1
- Authority
- CA
- Canada
- Prior art keywords
- composition according
- ophthalmic composition
- gel
- diclofenamide
- timolol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne une composition ophthalmologique se présentant sous forme de préparation en gel formant des gouttes et contenant de la diclofenamide se présentant sous sa forme libre et du timolol. L'invention concerne également l'utilisation de telles préparations en gel formant des gouttes pour traiter l'hypertension oculaire et les glaucomes à angle ouvert primaires et secondaires.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2002/005738 WO2003099258A1 (fr) | 2002-05-24 | 2002-05-24 | Preparation ophthalmologique en gel formant des gouttes et contenant de la diclofenamide et du timolol |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2481394A1 true CA2481394A1 (fr) | 2003-12-04 |
Family
ID=29558277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002481394A Abandoned CA2481394A1 (fr) | 2002-05-24 | 2002-05-24 | Preparation ophthalmologique en gel formant des gouttes et contenant de la diclofenamide et du timolol |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1507513A1 (fr) |
AU (1) | AU2002325220A1 (fr) |
CA (1) | CA2481394A1 (fr) |
WO (1) | WO2003099258A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10183076B2 (en) | 2005-05-16 | 2019-01-22 | Resdevco Research And Development Co. L | Topical compositions for treatment of irritation of mucous membranes |
USRE49758E1 (en) | 2012-01-23 | 2023-12-19 | Novaliq Gmbh | Stabilised protein compositions based on semifluorinated alkanes |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL168603A (en) * | 2005-05-16 | 2011-05-31 | Resdevco Res And Dev Co | Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells |
KR101656121B1 (ko) | 2010-03-17 | 2016-09-08 | 노바리크 게엠베하 | 안압 증가를 치료하기 위한 약학 조성물 |
EP3488847B1 (fr) | 2012-09-12 | 2023-11-08 | Novaliq GmbH | Compositions d'alcane semifluoré |
PL3355990T3 (pl) | 2015-09-30 | 2019-11-29 | Novaliq Gmbh | Semifluorowane związki oraz ich kompozycje |
ES2965677T3 (es) | 2016-09-23 | 2024-04-16 | Novaliq Gmbh | Composiciones oftálmicas que comprenden ciclosporina |
KR20200059272A (ko) | 2017-09-27 | 2020-05-28 | 노바리크 게엠베하 | 안구 질환의 치료에서의 사용을 위한 라타노프로스트를 포함하는 안과적 조성물 |
WO2019068763A1 (fr) | 2017-10-04 | 2019-04-11 | Novaliq Gmbh | Compositions ophtalmiques comprenant du f6h8 |
CA3091308A1 (fr) | 2018-03-02 | 2019-09-06 | Novaliq Gmbh | Compositions pharmaceutiques contenant du nebivolol |
CA3091313A1 (fr) * | 2018-03-28 | 2019-10-03 | Novaliq Gmbh | Composition pharmaceutique comprenant du timolol |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ192673A (en) * | 1979-02-02 | 1984-07-06 | Merck & Co Inc | Ophthalmic compositions for lowering intraocular pressure |
ATE9059T1 (de) * | 1980-01-28 | 1984-09-15 | Merck & Co. Inc. | Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension. |
US4678855A (en) * | 1985-10-09 | 1987-07-07 | Merck & Co., Inc. | Substituted benzenesulfonamides |
US6159458A (en) * | 1997-11-04 | 2000-12-12 | Insite Vision | Sustained release ophthalmic compositions containing water soluble medicaments |
DE50100416D1 (de) * | 2000-01-20 | 2003-08-28 | Mann Gerhard Chem Pharm Fab | Diclofenamid suspensionsgel |
-
2002
- 2002-05-24 CA CA002481394A patent/CA2481394A1/fr not_active Abandoned
- 2002-05-24 WO PCT/EP2002/005738 patent/WO2003099258A1/fr not_active Application Discontinuation
- 2002-05-24 EP EP02758204A patent/EP1507513A1/fr not_active Withdrawn
- 2002-05-24 AU AU2002325220A patent/AU2002325220A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10183076B2 (en) | 2005-05-16 | 2019-01-22 | Resdevco Research And Development Co. L | Topical compositions for treatment of irritation of mucous membranes |
USRE49758E1 (en) | 2012-01-23 | 2023-12-19 | Novaliq Gmbh | Stabilised protein compositions based on semifluorinated alkanes |
Also Published As
Publication number | Publication date |
---|---|
EP1507513A1 (fr) | 2005-02-23 |
AU2002325220A1 (en) | 2003-12-12 |
WO2003099258A1 (fr) | 2003-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11058684B2 (en) | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug | |
CA2186734A1 (fr) | Composition ophtalmique a viscosite reduite | |
EP2734206A1 (fr) | Combinaison à dose fixe de bimatoprost et brimonidine | |
JP2008532985A (ja) | 新規眼科用組成物及びその使用方法 | |
CA2481394A1 (fr) | Preparation ophthalmologique en gel formant des gouttes et contenant de la diclofenamide et du timolol | |
CN114585365A (zh) | 在假晶状体患者中使用拟副交感神经药物单独或与一种或多种α激动剂组合以产生多焦点 | |
WO2021039748A1 (fr) | Diquafosol ou sel correspondant et composition ophtalmique aqueuse contenant de la polyvinylpyrrolidone | |
WO2012149381A1 (fr) | Compositions et procédés pour améliorer la vision nocturne | |
RU2136252C1 (ru) | Противовоспалительные глазные капли | |
JPH05194271A (ja) | 局所眼薬組成物 | |
EP4029493A1 (fr) | Composition ophtalmique en nanoémulsion comprenant de la cyclosporine et du menthol, et son procédé de préparation | |
JP2002316926A (ja) | コンタクトレンズ用眼科用組成物及び眼刺激性の緩和方法 | |
GR1009419B (el) | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου | |
JPS6352609B2 (fr) | ||
WO2002040028A1 (fr) | Gouttes pour les yeux en gel antibacterien | |
ES2202271T3 (es) | Gel de suspension de diclofenamida. | |
EP0205606B1 (fr) | Compositions pharmaceutiques et leur utilisation comme agents mydriatiques | |
JPH07508745A (ja) | (s)−チモロール半水和物を含有する局所眼科治療用組成物及びその製造方法 | |
CA2015657A1 (fr) | Compose pharmaceutique | |
JPS6410497B2 (fr) | ||
AU770365B2 (en) | The process for manufacturing formulation of topical beta blockers with improved efficacy | |
WO2018174145A1 (fr) | Agent de prévention de la myopie, de traitement de la myopie, et/ou de prévention de la progression de la myopie comprenant de l'uméclidinium en tant que principe actif | |
EP0375299A1 (fr) | Mélanges d'inhibiteurs ACE et CA pour le traitement du glaucome | |
KR100261585B1 (ko) | 항염증점안제 | |
EP4142689A1 (fr) | Compositions ophtalmiques comprenant une combinaison de brinzolamide et de brimonidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |